PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer

BACKGROUND: Poor immunogenicity and extensive immunosuppressive T-cell infiltration in the tumor immune microenvironment (TIME) have been identified as potential barriers to immunotherapy success in “immune-cold” breast cancers. Thus, it is crucial to identify biomarkers that can predict immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hongmei, Xie, Chaoyu, Yao, Zhimeng, Zhao, Ruijun, Lin, Yusheng, Luo, Yichen, Chen, Shuanglong, Qin, Yanfang, Chen, Yexi, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393709/
https://www.ncbi.nlm.nih.gov/pubmed/36003382
http://dx.doi.org/10.3389/fimmu.2022.947841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393709/
https://www.ncbi.nlm.nih.gov/pubmed/36003382
http://dx.doi.org/10.3389/fimmu.2022.947841

Ejemplares similares